That musty “aging” odor comes from 2-nonenal, formed as skin oils oxidize with age and slower skin turnover lets it build ...

Evidence suggests colorectal cancer risk is highest with processed meats and heavy Western-style intake, while typical Indian ...

New long-term evidence shows that restoring normal blood sugar levels in people with prediabetes sharply reduces the risk of ...

In this free webinar, learn about the advantages of leveraging EPQT and AI-powered data quality in early phase QT assessment. The featured speakers will share considerations for determining whether ...

Joe DiMaggio Children's Hospital has earned national recognition as a Top Children's Hospital by The Leapfrog Group for its excellence in patient safety and quality of care. The national distinction ...

The Oliver Bell Group has filed a lawsuit on behalf of a woman whose life was permanently changed after a severe failure at Ascension St John Hospital.

Vial, a clinical-stage biotech company, today announced growing enthusiasm among metabolic disease KOLs for Vial's INHBE siRNA, a first-in-class, liver-targeted (GalNAc-conjugated) siRNA therapy that ...

ValuePenguin finds in 45 states, 2026 Premiums are Increasing by More Than 10% CHARLOTTE, N.C., Dec. 16, 2025 /PRNewswire/ -- Americans shopping for health insurance on the Affordable Care Act (ACA) ...

Advita Ortho, a global medical technology leader, has been awarded the Innovation award in the 2025 Medical Device Network Excellence Awards for its Newton® Balancing Technology for total knee ...

Partnering with Harvard-affiliated digital psychiatry researchers led by Dr. John Torous, the project will examine how AI tools perform when people seek help. ARLINGTON, Va., Dec. 16, 2025 /PRNewswire ...

OrthAlign, Inc., a global leader in surgical navigation technologies, today announced the expansion of its Lantern® Hip platform to ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or ...